Moore, R. G. (2026) “A Novel Marker for the Management of Patients Diagnosed with Endometrial Adenocarcinoma of the Uterus: HE4 a novel serum marker for endometrial cancer”, Clinical Journal of Obstetrics and Gynecology, 9(1), pp. 1–7. doi: 10.29328/journal.cjog.1001199.